Terms of Use

Terms of Use / Privacy Policy, Disclosure


These Terms of Use govern your use of this Web site (“Site”) and the Web pages contained herein. By using or accessing this Site and its Web pages, you agree to be bound by these Terms of Use and any and all modifications or changes to them. INA, INC, as the owner of this Site, may modify or change these Terms of Use at any time at its sole discretion. Therefore, you should read these Terms of Use carefully and regularly.

The information about you collected on the Site is subject to this Privacy Policy (“Policy”) and any and all changes to this Policy that may be made by the INA. This Policy describes what information we may collect from visitors to the Site, how we use this information, how we protect it, and what choices you have regarding the information. The effective date of this Policy is September 1, 2011.

Please be sure to read the Policy before using and submitting information on the Site. Your use of the Site is subject to this Policy as well as the Terms of Service. By accessing and/or using the Site, you agree to be bound by the terms of this Policy and any and all changes to this Policy that may be made by the INA. From time to time, our internal processes may change, or we may offer new or altered features on the Site. If appropriate, we may revise this Policy. We encourage you to return to this area to read the most recent version of our Policy. If you do not agree with the privacy practices described in this Policy, you should not use the Site.

1. Terms

INA, INC and its affiliates (collectively “we,” “us,” “our,” or “INA”), provide our Internet Site and the content, products, and services offered on or through the Site (collectively “Services”) to you subject to the following Terms and Conditions of Use. By accessing or using our Services, you accept and agree to be bound by these Terms and Conditions of Use, all applicable laws and regulations, and agree that you are responsible for compliance with any applicable local laws. If you do not agree with any of these terms, you are prohibited from using or accessing this Site or accepting the Services. The materials contained in this Site are protected by applicable copyright and trademark law.

THE CONTENT AND INFORMATION CONTAINED ON THIS WEB SITE IS NOT MEDICAL ADVICE. We include a lot of information on www.neurotoxins.org, including articles, references, tools, continuing education for medical professionals. Please remember that all of the information on www.neurotoxins.org, is meant for adults who are licensed healthcare professionals. While we hope you find the information on this Site helpful, you should remember that it is not meant to serve as a substitute for your own clinical judgment as a healthcare professional. If you are not a licensed healthcare professional and you choose to view the information on www.neurotoxins.org, you should not rely on the information as professional medical advice or use it to replace any relationship with your physician or other qualified healthcare professional. For any medical conditions and/or concerns, including but not limited to decisions about medications and/or other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.

2. Use License

Permission is granted to temporarily download one copy of the materials (information or software) on INA’s Web site for personal, noncommercial transitory viewing only, provided you keep intact all copyright and other proprietary notices. Use of the content or materials for any other purpose is prohibited. This is the grant of a limited revocable license, not a transfer of title, and under this limited license you may not: modify or copy the materials; use the materials for any commercial purpose, or for any public display (commercial or noncommercial); rent, lease, loan, sell, distribute, broadcast, or create derivative works based upon our content or software; attempt to decompile or reverse engineer any software contained on this Site; remove any copyright or other proprietary notations from the materials; or transfer the materials to another person or “mirror” the materials on any other server, in whole or in part.

This limited license shall automatically terminate if you violate any of these restrictions and may be terminated by the INA at any time, with or without cause. Upon terminating your viewing of these materials or upon the termination of this limited license, you must destroy any downloaded materials in your possession whether in electronic or printed format.

You acknowledge and agree that the Services and all contents and materials available on this site are protected by copyrights, trademarks, service marks, patents, trade secrets, or other proprietary rights and laws.

3. Disclaimer of Warranties

The Services, including the materials on the INA’s Web site, are provided “AS IS.” The INA makes no warranties, express or implied, and hereby disclaims and negates all other warranties, including without limitation, implied warranties or conditions of merchantability, fitness for a particular purpose, non-infringement of intellectual property, or other violation of rights. Further, the INA does not warrant or make any representations concerning the accuracy, likely results, or reliability of the Services or the use of the materials on its Site or otherwise relating to such Services or materials or on any sites linked to the INA’s Site.

The INA does not warrant that the Services or the functions on our Site will be uninterrupted or error-free, that defects will be corrected, or that the INA or the server that enables the Services to be available are free of viruses or other harmful components.

The information and opinions expressed in any Auditorium Events, Bulletin Boards, Chat Rooms, or other forums conducted on this Site are not necessarily those of the INA or its affiliated or related entities, and we make no representations or warranties regarding such information or opinions.

4. Limitations

In no event shall the INA or its affiliates or suppliers be liable for any damages, including, without limitation, any special, incidental or consequential damages that are directly or indirectly related to Services, (including, without limitation, damages for loss of data or profits, or due to business interruption) arising out of the Services or the use or inability to use the materials on the Site, even if the INA or an INA authorized representative has been notified orally or in writing of the possibility of such damage. Because some jurisdictions do not allow limitations on implied warranties, or limitations of liability for consequential or incidental damages, these limitations may not apply to you.

5. Revisions and Errata

The Services and materials appearing on the Site could include technical, typographical, or photographic errors. The INA does not warrant that any of the materials on its Site are accurate, complete, or current. The INA may make changes to its Services and the materials contained on its Site at any time without notice. The INA does not, however, make any commitment to update the materials.

6. Links

The INA has not reviewed all of the sites linked to its Site and is not responsible for the contents of any such linked site. The inclusion of any link does not imply endorsement by the INA of the other sites. Use of any such linked site is at the user’s own risk.

7. Usage Outside the US

The INA makes no representation that the Services or materials on this Site are appropriate or available for use in locations outside the United States, and accessing them from territories where their contents are illegal is prohibited. Those who choose to use the Services or access this Site from other locations do so on their own initiative, and are responsible for compliance with local laws.

8. Indemnification

You shall indemnify, defend, and hold harmless the INA and its affiliates, their officers, directors, employees, and agents (collectively, the “Indemnified Parties”), from and against any and all claims, losses, damages, liabilities, judgments, and fees and expenses related thereto (including, without limitation, reasonable attorneys’ fees), incurred by an Indemnified Party in connection with any claims arising out of, based upon, or resulting from any breach, or violation by you of this Agreement, or any use by you of the Services, or this Site, or as a result of a dispute with another user.

9. Terms of Use Modifications

The INA may revise the Services, and the Terms and Conditions of Use at any time without notice. By accepting the Services and using this Site you are agreeing to be bound by the then current version of these Terms and Conditions of Use.

10. Governing Law

Any claim relating to the Services and this Site shall be governed by the laws of the State of New York, without regard to its conflict of law provisions.

General Terms and Conditions Applicable to Use of Services and This Site.


Your privacy is very important to us. Accordingly, we have developed this Privacy Policy (“Policy”) in order for you to understand how we collect, use, communicate, disclose, and make use of personal information. The following outlines our Policy.

Before or at the time of collecting personal information, we will identify the purposes for which information is being collected. We will collect and use personal information solely with the objective of fulfilling those purposes specified by us and for other compatible purposes, unless we obtain the consent of the individual concerned, or as required by law. When users request pages from our server, our Web server automatically collects some information about the users, including their IP addresses. These addresses are used by computers on the network to send the requested pages to users. In order to access certain portions of our Site, users must register and provide certain voluntary information about themselves. We will only retain personal information as long as necessary for the fulfilment of those purposes. We will collect personal information by lawful and fair means and, where appropriate, with the knowledge or consent of the individual concerned. Personal data should be relevant to the purposes for which it is to be used, and, to the extent necessary for those purposes, should be accurate, complete, and up-to-date.

We will protect personal information by reasonable security safeguards against loss or theft, as well as unauthorized access, disclosure, copying, use, or modification. We will make readily available to customers information about our policies and practices relating to the management of personal information. We are committed to conducting our business in accordance with these principles in order to ensure that the confidentiality of personal information is protected and maintained.

1. Using E-mail Addresses Provided at Registration

We periodically send out e-mail newsletters and promotional e-mail to our users about Services and products offered by our main Site. Users can indicate that they do not wish to receive e-mail information from us. Third parties will not contact our users through the use of our e-mail newsletter.

2. TOXINS Conferences and Other Educational Activities

When you register for a TOXINS conference or other educational activity [Continuing Medical Education (“CME”) or a Continuing Education (“CE”)] through the Site, we collect certain personal identifiable information from you such as your name, e-mail address, and mailing address. In addition to personal identifiable information, we collect aggregated nonpersonal identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:

1. We provide personal identifiable information to CME/CE providers who certify CME/CE activities posted on www.neurotoxins.org, as required by the ACCME and other accrediting bodies. This information may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the CME/CE provider for up to six (6) years;

2. Commercial supporters of CME/CE activities on the Site will receive aggregated data about CME/CE activities that are relevant to their interests and/or the courses they support;

3. INA staff will have internal access to files containing personally identifiable information, including evaluation forms and aggregated CME/CE participant information. These files can be accessed for reasons including providing responses to your questions or comments. Our staff may also use personally identifiable information, including registration information and evaluation data, in assessing educational needs and planning marketing activities; and we may use the information we collect as otherwise permitted in this Policy.

3. Not Intended for Use by Minors

The Site is not intended for, nor do we believe it is appealing to, children under the age of 18. We will not knowingly collect information from visitors to the Site in this age group. We do not specifically collect, use, or disclose information about children under the age of 18.

4. Changes

Updated versions of this Privacy Policy will be posted on this page. Current version posted: 09/11.

5. Consent

Notwithstanding any provisions to the contrary in this Privacy Policy, you expressly consent and agree to allow the INA to view, compile, collect, use in any way, modify, copy, display, distribute, reproduce, process, disclose, transmit, and create derivative works from all or any portion(s) of your personal and other information. By submitting and/or entering your information to this Site and its Web pages, you agree to and grant the INA an irrevocable, perpetual, nonexclusive, royalty-free, worldwide license and right to view, compile, collect, use in any way, modify, copy, display, distribute, reproduce, process, disclose, transmit, and create derivative works from all or any portion of your personal and other information. However, the INA is not obligated to use your information, and the INA reserves its rights to delete and to refuse to use your information, at the INA ‘s sole discretion. Without limiting the foregoing, you agree that the INA may submit and disclose your personal and other information to third parties for business purposes and all other lawful purposes. The INA is not responsible for the privacy or security practices of any third parties.


The TOXINS conferences and other educational activities on this Site or linked to from this SITE may mention the use of medications for both FDA-approved and non-approved indications.

The INA Site is administered by Scientiae LLC, 48 Wall Street, Suite 1100, New York, NY 10005.

New Abstract Topic

International Forum: Exploring the National, Regional, and Local Clinical Experience With Botulinum Neurotoxins

In recognition of the country-specific and/or institution-specific differences in the use of BoNTs in clinical practice, this session is designed for clinicians and research scientists to share their experience and insights with global colleagues. A session format combining presentations and a panel discussion will identify and explore these differences in the clinical application of BoNTs relating to: patient populations, treatment protocols, best practices for common indications, pharmacoeconomic considerations, and data for the use of BoNT therapy in innovative ways.

You have Successfully Subscribed!

Cancellation policy:

30 days prior to arrival cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

You have Successfully Subscribed!

Parking (Focus car park)

We offer the opportunity to pre-book parking in our enclosed section in the nearby Focus car park (Fabriksgatan 45) for 225 SEK/night (valid from 15:00 on the day of your arrival until 13:00 on the day of your departure).

The easiest way to pre-book is when you reserve a room or online via the link you receive in your confirmation or welcome e-mail from us 7 days before your arrival. Alternately, contact the reservations team by e-mail: room@gothiatowers.com or telephone: +46 (0)31-750 88 10.

If you have not pre-booked a parking space or you would like parking after hours, a space may be provided subject to availability. Please contact the Guest Service team at the hotel.

Swedish, Danish, and Norwegian cars:
If you have pre-booked and provided us with your car license number and a mobile phone number, you can drive directly to the Focus car park (Fabriksgatan 45) before checking in.

The car’s license plate will be scanned and the barrier will then open automatically for you at the entrance to the hotel’s enclosed section. The last six digits of your mobile number will be used as a code for the gate when you collect your car.

Cars from other countries, motorcycles, or cars with a personalised license plate:
Our system is unable to read these license plates, and you do not need to provide your license number. Instead, please collect a ticket from Guest Service before driving to the car park.

If you have not pre-booked parking, contact Guest Service when you arrive and they will help you to book a space, subject to availability.

You have Successfully Subscribed!

Group Accommodations Cancellation Policy:

In the event of cancellation of accommodation, the Purchaser may cancel the contracted hotel rooms with no charge up to 180 days prior to arrival.

This is considered the latest allowed date for timely cancellations free of charge. Significant modifications to the booking may result in a re-evaluation of rates and conditions offered.

After this date (180 days) no more than 50% of the reserved rooms per day can be cancelled.

Please note, that in order to cancel the maximum of 50% allowed, the cancellation should occur during period 1 (see below). The original reservation is defined as all rooms (inclusive of VAT) reserved and confirmed on the date stipulated as the last allowed for cancellations.

Period 1: 179-120 days prior to arrival a maximum of 50% of the original reservation per day may be cancelled with no charge.

Period 2: 119-90 days prior to arrival a maximum of 35% of the original reservation per day may be cancelled with no charge.

Example: If a total of 35% or more has already been cancelled during period 1, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 15% has been cancelled during period 1, it is possible to cancel additional 20% during period 2, so the total cancellation does not exceed 35% of the final reserved event.

Period 3: During the period of 89- 60 days prior to arrival a maximum of 10% of the final reservation per day may be cancelled with no charge.

Example: If a total of 10% or more has already been cancelled during period 1 and 2, it will not be possible to make any further changes or reduction without incurring a charge s. If, for example, 5% has been cancelled during period 1 and 2, it is possible to cancel additional 5% during period 3, so the total cancellation does not exceed 10% of the final reserved event.

Period 4: During the period of 59-20 days prior to arrival a maximum of 5% of the final reservation per day may be cancelled with no charge.

Example: If a total of 5% or more has already been cancelled during period 1, 2 and 3, it will not be possible to make any further changes or reductions without incurring a charge. If, for example, 2% has been cancelled during period 1, 2 and 3, it is possible to cancel additional 3% during period 4, so the total cancellation does not exceed 5% of the final reserved event.

After period 4, cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

In the case of no-shows, delayed arrival or early departure the hotel is entitled to payment equivalent to the full price of the original reservation (all nights) as booked.

All changes and amendments by the client have to be confirmed in writing by the Hotel to be validated.

A contract addendum will be sent and should be signed by client for any changes above original contracted room booking.

You have Successfully Subscribed!

Abstract Presentation Note

Awaiting Content

Donec at viverra nulla, eu hendrerit augue. Nam pharetra, diam eget sagittis malesuada, quam purus mollis tellus, in aliquet purus nulla sit amet dui. Fusce eu dolor ultrices, condimentum lorem quis, luctus ante. Nunc ligula erat, mattis a libero ut, finibus porta lectus. In aliquet arcu sed cursus sagittis. Pellentesque vitae pretium urna. Cras sit amet volutpat nunc, eu gravida neque. Vestibulum eu feugiat nulla, eu dignissim lacus. Sed dignissim, lacus et viverra finibus, arcu mi commodo ipsum, interdum faucibus elit turpis sit amet lacus. Maecenas aliquam metus massa, sed commodo enim tempus nec.

You have Successfully Subscribed!

General Guidelines for Abstract Review

Eligible abstracts should present original research on the science of botulinum neurotoxins or their clinical application. Abstracts should be current and of broad interest and importance to those engaged in the field of botulinum neurotoxin research and therapeutics.

Each abstract should be concise and factual. An abstract should briefly state the purpose of the research, the principal results, and major conclusions. Abstracts must be submitted in English.

All abstract(s) should be unbranded; generic names should be used after first mention of product brand names.

Financial support of the research being submitted in the abstract should be indicated if applicable.

Both structured and unstructured abstracts are acceptable. Other (unstructured) abstracts will not follow this format but should contain the same information.

Structured abstracts should be formatted as follows:

• Abstract title
• Authors’ names and affiliations
• Corresponding author contact information

This section should briefly state the precise objectives of the research or study question and explanatory background.

The experimental methodology should be clearly described.

Results should be clear and concise. The main outcomes of the study should be reported and quantified.

The main conclusions that are supported by the study should be presented indicating clinical/research or health policy implications.

You have Successfully Subscribed!

Share This